Bacterial endotoxins are lipopolysaccharide (LPS) molecules found in the outer membrane of Gram-negative bacteria. Even after sterilization kills the bacteria themselves, endotoxins can persist and cause severe pyrogenic reactions in humans — including fever, septic shock, and in extreme cases, death. This makes endotoxin testing one of the most critical quality control steps for any product that contacts the bloodstream, cerebrospinal fluid, or other sterile body compartments.
What Is USP <85>?
United States Pharmacopeia Chapter <85>, titled "Bacterial Endotoxins Test," defines the official methodology for detecting and quantifying endotoxins in pharmaceutical products, medical devices, and biologics. The chapter specifies the use of Limulus Amebocyte Lysate (LAL), a reagent derived from the blood of horseshoe crabs that reacts specifically with bacterial endotoxins.
USP <85> describes three validated LAL techniques, each suited to different product types and laboratory workflows:
Gel-Clot Method — The original and simplest LAL technique. A sample is mixed with LAL reagent and incubated at 37°C for one hour. If endotoxin is present above the labeled sensitivity of the lysate, the mixture forms a firm gel clot. This is a pass/fail test that provides qualitative results and is often used for routine lot release testing.
Turbidimetric Method (Kinetic Turbidimetric Assay, KTA) — This method measures the increase in turbidity (cloudiness) as the LAL reagent reacts with endotoxin over time. A spectrophotometer continuously monitors the optical density of the reaction mixture, and the time required to reach a threshold turbidity is inversely proportional to the endotoxin concentration. KTA provides quantitative results and is well-suited for high-throughput testing.
Chromogenic Method (Kinetic Chromogenic Assay, KCA) — Similar in principle to the turbidimetric method, but uses a synthetic chromogenic substrate that releases a yellow color (p-nitroaniline) when cleaved by the LAL enzyme cascade. The rate of color development is proportional to endotoxin concentration, measured by absorbance at 405 nm. This method offers excellent sensitivity and quantitative precision.
Why Endotoxin Testing Matters
The FDA requires endotoxin testing for all parenteral drugs, biological products, and medical devices that contact blood or cerebrospinal fluid. The endotoxin limit for most injectable drugs is 5 EU/kg body weight, while intrathecal products have a much stricter limit of 0.2 EU/kg.
Beyond regulatory compliance, endotoxin testing is essential for:
- Patient safety — Endotoxins trigger the innate immune system, causing inflammatory cytokine release that can lead to fever, hypotension, organ failure, and death.
- Product quality — Elevated endotoxin levels indicate contamination during manufacturing, pointing to process control failures that need investigation.
- Research integrity — In cell culture and in vivo studies, endotoxin contamination can confound experimental results by activating immune pathways unrelated to the test article.
Common Challenges and How to Address Them
Low Endotoxin Recovery (LER) — Some formulations, particularly those containing chelating agents, surfactants, or citrate buffers, can mask endotoxin and cause falsely low results. The FDA has issued guidance recommending hold-time studies to verify that endotoxin remains detectable in the sample matrix over the maximum hold time before testing.
Interfering Substances — Product components can either inhibit or enhance the LAL reaction. USP <85> requires that every product undergo an inhibition/enhancement validation to confirm that the test system performs accurately in the presence of the sample matrix.
Sample Preparation — Proper dilution is critical. The Maximum Valid Dilution (MVD) calculation ensures that the sample is diluted enough to overcome interference but not so much that endotoxin falls below the detection limit.
How ILS Laboratories Performs Endotoxin Testing
At ILS Laboratories, we use the kinetic turbidimetric LAL method on validated instrumentation for quantitative endotoxin determination. Our approach includes full inhibition/enhancement validation for each unique product matrix, ensuring accurate and defensible results.
Every test is performed under our ISO 17025 quality management system with full traceability from sample receipt through result reporting. Results are delivered on a QR-verified Certificate of Analysis, typically within 3–5 business days of sample receipt.
Whether you are testing peptides, injectables, medical device extracts, or raw materials, our endotoxin testing program is designed to meet FDA expectations and support your regulatory submissions with confidence.